A Phase-2 Pilot Study of a Therapeutic Combination of Δ9-Tetrahydracannabinol and Palmitoylethanolamide for Adults With Tourette's Syndrome.

Objective: There are few effective pharmacological treatments for Tourette’s syndrome. Many patients with Tourette’s syndrome experience impairing tic symptoms despite use of available evidence-bas...